Industry Researchers On Drugs

Posted by Pile (9726 views) Add this story to MyYahoo Add this article to del.icio.us Submit article to Reddit Add story to Furl Add story to StumbleUpon [E-Mail link]


[Dubious Research]
The American Journal of Psychiatry analyzed every publicly available trial funded by the pharmaceutical industry pitting five new antipsychotic drugs against one another. Not surprisingly, nine in 10 trials claimed that the best drug was the one made by the company funding the study.

Pharmaceutical giant Eli Lilly and Co. recently funded five studies that compared its antipsychotic drug Zyprexa with Risperdal, a competing drug made by Janssen. All five showed Zyprexa was superior in treating schizophrenia.

But when Janssen sponsored its own studies comparing the two drugs, Risperdal came out ahead in three out of four.

Often, the problem is not outright fabrication. Some industry-funded studies "use too low a dose of a competitor's drug, while others choose statistical techniques that show their drug in the best light.

Details

 

 

Comments

 
Name: (change name for anonymous posting)
Title:
Comments:
   

1 Article displayed.

Pursuant to Section 230 of Title 47 of the United States Code (47 USC § 230), BSAlert is a user-contributed editorial web site and does not endorse any specific content, but merely acts as a "sounding board" for the online community. Any and all quoted material is referenced pursuant to "Fair Use" (17 U.S.C. § 107). Like any information resource, use your own judgement and seek out the facts and research and make informed choices.

Powered by Percleus (c) 2005-2047 - Content Management System

[Percleus 0.9.4] (c) 2005, PCS